Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19

Detalles Bibliográficos
Autores principales: Hernández-Coronado, Marcela, Gómez-Almaguer, David, Jaime-Pérez, José Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446262/
https://www.ncbi.nlm.nih.gov/pubmed/34253503
http://dx.doi.org/10.1016/j.htct.2021.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446262/
https://www.ncbi.nlm.nih.gov/pubmed/34253503
http://dx.doi.org/10.1016/j.htct.2021.05.005

Ejemplares similares